Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Previously diagnosed Type II Diabetes patients having Fasting blood sugar more than 110 mg/dl Postprandial more than 140 mg/dl Random blood sugar 180 mg/dl HbA1C more than 7 with peripheral neuropathy(Sensory)
Exclusion criteria
Exclusion criteria: Type I Diabetes mellitus Diabetes Insipidus Gestational Diabetes mellitus Chronic Kidney diseases having S Creatinine more than 2 mg/dl Motor neuron disease Presence of foot ulcer Myopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| During treatment or after treatment reduction of following symptoms Glucose level within normal limit HbA1C below 6mg/dl Reduction in numbness in the limbs reduction in general tiredness,malaise.Timepoint: 90 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of physicochemical,phytochemical,pharmacological activities of Alli Chooranam. Evaluation of Siddha parameters (including Envagai thervu) in Kapha Neerizhivu during trial period. Evaluation of safety profile for acute and Sub acute toxicity of trial drug.Timepoint: 90 days | — |
Countries
India
Contacts
Government Siddha Medical College & Hospital Palayamkottai